+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Bilfinger Tebodin BV - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 20 Pages
  • July 2026
  • GlobalData
  • ID: 3053045
Bilfinger Tebodin BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Bilfinger Tebodin BV (Bilfinger Tebodin), a subsidiary of Bilfinger SE, is a provider of consulting and engineering services. It offers services project management, engineering, procurement, construction management, consultancy services, maintenance solutions, turnaround solutions, insulation, scaffolding and corrosion protection. Bilfinger Tebodin also offers inspection services, mechanical services, digitalization and asset management. The company serves the energy, chemicals and petrochemicals, pharmaceuticals, water, oil and gas and food sectors. It operates its offices across various countries in Northwest Europe, Central Europe and Eastern Europe. Bilfinger Tebodin is headquartered in Hague, the Netherlands.

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Pharming Group NV - Key Facts
  • Pharming Group NV - Key Employees
  • Pharming Group NV - Key Employee Biographies
  • Pharming Group NV - Major Products and Services
  • Pharming Group NV - History
  • Pharming Group NV - Company Statement
  • Pharming Group NV - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Pharming Group NV - Business Description
  • Product Category: Joenja
  • Performance
  • Product Category: Ruconest
  • Performance
  • Geographical Segment: Europe and RoW
  • Performance
  • Geographical Segment: US
  • Performance
  • R&D Overview
  • Pharming Group NV - Corporate Strategy
  • Pharming Group NV - SWOT Analysis
  • SWOT Analysis - Overview
  • Pharming Group NV - Strengths
  • Pharming Group NV - Weaknesses
  • Pharming Group NV - Opportunities
  • Pharming Group NV - Threats
  • Pharming Group NV - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Pharming Group NV, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Pharming Group NV, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Pharming Group NV, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 02, 2026: Pharming Group to Participate in the Jefferies Global Healthcare Conference in New York
  • May 28, 2026: Pharming Group Announces Results of 2026 Annual General Meeting of Shareholders
  • Mar 12, 2026: Pharming Group Reports Fourth Quarter and Full-Year 2025 Financial Results
  • Feb 26, 2026: Pharming Group to Report Fourth-Quarter and Full-Year 2025 Financial Results and Provide Business Update
  • Feb 17, 2026: Pharming Group to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
  • Jan 08, 2026: Pharming Group Reports Preliminary 2025 Revenues and Announces Investor Day
  • Oct 30, 2025: Pharming Group Participates in Fireside Chat at Jefferies Global Healthcare Conference
  • Oct 20, 2025: Pharming Group Presents New Data at 2025 ACAAI Annual Scientific Meeting
  • Oct 06, 2025: Pharming Group Updates G&A Expense Reduction Plan
  • Oct 01, 2025: Pharming Group Announces FDA Acceptance and Priority Review of Supplemental NDA for Leniolisib in Children with APDS Aged 4 to 11 Years
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Pharming Group NV, Key Facts
  • Pharming Group NV, Key Employees
  • Pharming Group NV, Key Employee Biographies
  • Pharming Group NV, Major Products and Services
  • Pharming Group NV, History
  • Pharming Group NV, Other Locations
  • Pharming Group NV, Subsidiaries
  • Pharming Group NV, Key Competitors
  • Pharming Group NV, Ratios based on current share price
  • Pharming Group NV, Annual Ratios
  • Pharming Group NV, Interim Ratios
  • Pharming Group NV, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Pharming Group NV, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Pharming Group NV, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Pharming Group NV, Performance Chart (2021 - 2025)
  • Pharming Group NV, Ratio Charts
  • Pharming Group NV, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Pharming Group NV, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026